Overview
Cardiac hypertrophy is an abnormal thickening and enlargement of the heart muscle, particularly the walls of the chambers that pump blood, in response to increased workload or stress on the heart. It develops when the heart must work harder over time, most commonly as a result of chronic high blood pressure, which forces the left ventricle to contract against elevated resistance, but it can also arise from valve disease, certain inherited conditions, and other cardiovascular disorders. While some thickening can initially be a compensatory adaptation, sustained hypertrophy stiffens the heart, impairs its ability to fill and pump efficiently, and raises the risk of heart failure, arrhythmias, and other complications. Diagnosis relies on imaging such as echocardiography and on electrocardiography, and management centers on treating the underlying cause, especially controlling blood pressure, to halt or reverse the process. As a condition closely tied to hypertension and cardiac function, cardiac hypertrophy falls within the scope of Hypertension and Cardiology. Research relevant to the journal includes work on cardiorenal signaling pathways in heart failure, microRNAs in hypertension and ischemic heart disease, and cardiac and kidney remodeling in experimental hypertension, reflecting its coverage of the cardiovascular consequences of high blood pressure. This page gathers peer-reviewed, open-access research relevant to cardiac hypertrophy and hypertensive heart disease.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
MicroRNA: New Era for Therapeutic Strategy in Ischaemic Heart Disease
MicroRNAs: As A Novel Potential Tool for Diagnosis, Prognosis, and Therapeutic Agents in Hypertension.
Edpidemiology, Clinical Profile and Short- Term Outcome of Hypertensive Crisis in N'Djamena (Chad)
Cardiac Mechanics in Patients with Systemic Hypertension with Normal EF: A Speckle - Strain Imaging Study
A Role for in Vitro Disease Models in the Landscape of Preclinical Cardiotoxicity and Safety Testing
Rheumatic Heart Disease In Chad: Clinical, Paraclinical, Therapeutic And Progressive Aspects
Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients
Assessment of Cardiac Function and Prevalence of Sleep Disordered Breathing using Ambulatory Monitoring with Acoustic Cardiography – Initial Results from SWICOS
Evaluation of Cardiac Performance after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
Apical Hypertrophic Cardiomyopathy and Multiple Coronary Artery-Left Ventricular Fistulas: A Case Report.
How this research is being cited
The 12 articles above have been cited 18 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · Journal of the American Heart Association
-
2024 · Journal of the American Heart Association
-
2023 · Biosensors
-
2023 · Biomedical and Pharmacology Journal
-
2023 · Biosensors
-
2022 · The European Research Journal
-
2022 · The European Research Journal
-
2021 · Clinical Cardiology
A sample of recent works citing this journal's research on Cardiac Hypertrophy, linking to each citing work.